Compare CVS Health Corp (CVS) vs Sezzle Inc (SEZL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Sezzle Inc — how do they compare? CVS Health Corp trades at $94.06 (market cap $119.58B), while Sezzle Inc trades at $125.13 (market cap $4.32B). The key difference: CVS Health Corp is far larger — about 27.7× Sezzle Inc's market cap, and CVS Health Corp pays a 2.84% dividend while Sezzle Inc pays none. Which is the better fit depends on your goals.
| CVS | SEZL | |
|---|---|---|
Market Cap | $119.58B | $4.32B |
Sector | Health | Technology |
52-Week High | $110.60 | $188.55 |
52-Week Low | $65.51 | $50.97 |
Enterprise Value | $181.93B | $4.36B |
Dividend Yield | 2.84% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $95.67, down slightly by 0.03% today. The stock shows strong fundamental momentum with recent quarterly earnings beats, including Q2 2026 EPS of $2.58 versus $1.87 expected, and raised 2026 guidance. Valuation metrics appear reasonable with a P/E of 24.67 and P/S of 0.29. Technical indicators are mixed with a bullish overall signal but bearish moving averages, with key support at $95 and resistance at $96.
The outlook for CVS is positive, supported by earnings strength and analyst consensus, but risks include margin pressure and rising debt levels. The consensus price target of $115.90 implies significant upside, though investors should monitor execution on guidance and healthcare regulatory changes.
SEZL stock trades at $125.81, up 6.62% with strong quarterly earnings beats and raised 2026 guidance. The company demonstrates robust fundamentals with 30.35% net income margin and 88.85% ROE, though technical indicators show bearish momentum with current price near support at $125. Recent institutional buying and positive analyst coverage (50% buy ratings) support the growth narrative despite elevated valuation multiples.
The outlook remains positive given consecutive earnings beats and 35% revenue growth guidance, though the stock faces technical headwinds and premium valuation risks. Execution on AI initiatives and everyday money expansion could drive further upside toward the $158.29 consensus target, but investors should monitor margin pressures and competitive threats in the BNPL space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Sezzle Inc
Sezzle Inc is a financial technology company that operates a Buy Now, Pay Later (BNPL) payment platform. The company allows consumers to make purchases and split the total cost into four interest-free payments over six weeks, primarily serving the e-commerce retail market. Sezzle focuses on promoting financial empowerment by offering a transparent and responsible payment solution to customers at the point of sale.
Read more on SEZL →
